These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
391 related items for PubMed ID: 7906974
1. Inhibition of functional and immunological responses to thyroid-stimulating antibodies from patients with Graves' disease by blockade of the thyrotropin receptor. Hoermann R, Schumm-Draeger PM, Mann K. Thyroid; 1993; 3(4):273-8. PubMed ID: 7906974 [Abstract] [Full Text] [Related]
2. Regulation of intercellular adhesion molecule-1 expression in human thyroid cells in vitro and human thyroid tissue transplanted to the nude mouse in vivo: role of Graves' immunoglobulins and human thyrotropin receptor. Hoermann R, Spitzweg C, Poertl S, Mann K, Heufelder AE, Schumm-Draeger PM. J Clin Endocrinol Metab; 1997 Jul; 82(7):2048-55. PubMed ID: 9215271 [Abstract] [Full Text] [Related]
6. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor. Islam N, Tuppal R, Hawe BS, Briones-Urbina R, Farid NR. J Cell Biochem; 1986 Jan; 31(2):107-20. PubMed ID: 2426288 [Abstract] [Full Text] [Related]
7. Antagonists of the human TSH receptor: in vitro and in vivo studies of their functional and immunological effects. Hoermann R, Schumm-Draeger PM, Mann K. Exp Clin Endocrinol; 1992 Jan; 100(1-2):36-40. PubMed ID: 1468513 [Abstract] [Full Text] [Related]
8. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins. Heyma P, Harrison LC. J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581 [Abstract] [Full Text] [Related]
9. Monoclonal pathogenic antibodies to the thyroid-stimulating hormone receptor in Graves' disease with potent thyroid-stimulating activity but differential blocking activity activate multiple signaling pathways. Gilbert JA, Gianoukakis AG, Salehi S, Moorhead J, Rao PV, Khan MZ, McGregor AM, Smith TJ, Banga JP. J Immunol; 2006 Apr 15; 176(8):5084-92. PubMed ID: 16585606 [Abstract] [Full Text] [Related]
10. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors. Kosugi S, Ban T, Akamizu T, Kohn LD. Mol Endocrinol; 1992 Feb 15; 6(2):168-80. PubMed ID: 1349156 [Abstract] [Full Text] [Related]
11. Extracts and auto-oxidized constituents of certain plants inhibit the receptor-binding and the biological activity of Graves' immunoglobulins. Auf'mkolk M, Ingbar JC, Kubota K, Amir SM, Ingbar SH. Endocrinology; 1985 May 15; 116(5):1687-93. PubMed ID: 2985357 [Abstract] [Full Text] [Related]
12. Effects of recombinant human interleukin-2 and tumor necrosis factor-alpha with or without interferon-gamma on human thyroid tissues from patients with Graves' disease and from normal subjects xenografted into nude mice. Kasuga Y, Matsubayashi S, Akasu F, Miller N, Jamieson C, Volpé R. J Clin Endocrinol Metab; 1991 Jun 15; 72(6):1296-301. PubMed ID: 1902846 [Abstract] [Full Text] [Related]
13. Differential effects of human interferon alpha and interferon gamma on xenografted human thyroid tissue in severe combined immunodeficient mice and nude mice. Kawai K, Enomoto T, Fornasier V, Resetkova E, Volpé R. Proc Assoc Am Physicians; 1997 Mar 15; 109(2):126-35. PubMed ID: 9069581 [Abstract] [Full Text] [Related]
14. Effect of removing human Graves' thyroid xenografts after eight weeks in nude mice and rexenografting them into SCID mice. Yoshikawa N, Arreaza G, Morita T, Mukuta T, Resetkova E, Akasu F, Miller N, Jamieson C, Volpé R. J Clin Endocrinol Metab; 1994 Feb 15; 78(2):367-74. PubMed ID: 8106624 [Abstract] [Full Text] [Related]
15. Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera. Rotella CM, Zonefrati R, Toccafondi R, Valente WA, Kohn LD. J Clin Endocrinol Metab; 1986 Feb 15; 62(2):357-67. PubMed ID: 2416769 [Abstract] [Full Text] [Related]
16. Antibody to gp39, the ligand for CD40 significantly inhibits the humoral response from Graves' thyroid tissues xenografted into severe combined immunodeficient (SCID) mice. Resetkova E, Kawai K, Enomoto T, Arreaza G, Togun R, Foy TM, Noelle RJ, Volpé R. Thyroid; 1996 Aug 15; 6(4):267-73. PubMed ID: 8875745 [Abstract] [Full Text] [Related]
17. Unaltered thyroid function in mice responding to a highly immunogenic thyrotropin receptor: implications for the establishment of a mouse model for Graves' disease. Carayanniotis G, Huang GC, Nicholson LB, Scott T, Allain P, McGregor AM, Banga JP. Clin Exp Immunol; 1995 Feb 15; 99(2):294-302. PubMed ID: 7851025 [Abstract] [Full Text] [Related]
18. Thyroid xenografts from patients with Graves' disease in severe combined immunodeficient mice and NIH-beige-nude-xid mice. Mukuta T, Arreaza G, Nishikawa M, Resetkova E, Jamieson C, Tamai H, Volpé R. Clin Invest Med; 1997 Feb 15; 20(1):5-15. PubMed ID: 9013039 [Abstract] [Full Text] [Related]
19. Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotrophin binding sites in guinea pig fat cell membranes. Development of a direct enzyme immunoassay. Baker JR, Lukes YG, Smallridge RC, Berger M, Burman KD. J Clin Invest; 1983 Oct 15; 72(4):1487-97. PubMed ID: 6138364 [Abstract] [Full Text] [Related]
20. The extracellular domain of the TSH receptor has an immunogenic epitope reactive with Graves' IgG but unrelated to receptor function as well as determinants having different roles for high affinity TSH binding and the activity of thyroid-stimulating autoantibodies. Kosugi S, Akamizu T, Takai O, Prabhakar BS, Kohn LD. Thyroid; 1991 Oct 15; 1(4):321-30. PubMed ID: 1726785 [Abstract] [Full Text] [Related] Page: [Next] [New Search]